BABY Share Price

Open 37.05 Change Price %
High 37.70 1 Day 0.65 1.76
Low 36.95 1 Week -1.10 -2.84
Close 37.65 1 Month 2.65 7.57
Volume 295328 1 Year 0.89 2.42
52 Week High 44.39
52 Week Low 29.54
BABY Important Levels
Resistance 2 38.35
Resistance 1 38.06
Pivot 37.43
Support 1 37.24
Support 2 36.95
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
AAPL 120.00 0.18%
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%

Natus Medical Incorporated (NASDAQ: BABY)

BABY Technical Analysis 1.5
As on 20th Jan 2017 BABY Share Price closed @ 37.65 and we RECOMMEND Buy for LONG-TERM with Stoploss of 37.50 & Sell for SHORT-TERM with Stoploss of 38.30 we also expect STOCK to react on Following IMPORTANT LEVELS.
BABY Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
BABY Other Details
Segment EQ
Market Capital 360599776.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website
BABY Address
1501 Industrial Road
San Carlos, CA 94070
United States
Phone: 650-802-0400
Fax: 650-802-0401
BABY Latest News
Natus Medical Inc. (BABY) Given Consensus Recommendation of "Buy" by Brokerages   BBNS   - 20th Jan 17
Natus Medical Closes GN Otometrics Business Acquisition   Yahoo Finance   - 04th Jan 17
Natus Medical Inc.: This BABY Keeps Chugging Along   Motley Fool   - 20th Oct 16
Why Natus Medical Inc Slipped Today   Motley Fool   - 26th Sep 16
How Natus Medical Inc. Got Back on Track   Motley Fool   - 21st Jul 16
3 Things to Watch As Natus Medical Inc Reports Earnings   Motley Fool   - 19th Jul 16
Natus Medical Inc Says Adios to Venezuela Guidance   Motley Fool   - 21st Apr 16
Why Natus Medical Inc. Reported Lower Today   Motley Fool   - 04th Apr 16
Natus Medical Inc. Serving Up Earning Growth   Motley Fool   - 28th Jan 16
1 Thing to Watch As Natus Medical Inc. Reports Earnings   Motley Fool   - 26th Jan 16
Interactive Technical Analysis Chart Natus Medical Incorporated ( BABY NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Natus Medical Incorporated
BABY Business Profile
Natus Medical Incorporated (Natus), incorporated in May 1987, is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. Natus categorizes its products into three categories: Hearing, Neurology and Newborn Care. On September 15, 2011, it acquired Embla Systems LLC. In July 2012, the Company acquired the Nicolet neurodiagnostic business from CareFusion. Hearing includes products for newborn hearing screening and diagnostic hearing assessment. The Company’s newborn hearing screening techniques consists of auditory brainstem response (ABR) and otoacoustic emission (OAE). Its newborn hearing screening product lines consist of the ALGO, ABaer, AuDX and Echo-Screen newborn hearing screeners. These hearing screening products utilize signal detection technologies to provide non-invasive hearing screening for newborns and are designed to detect hearing loss at 35 decibel above normal adult hearing level (dB nHL) or higher. Its AABR devices deliver thousands of soft audible clicks to the newborn’s ears through sound cables and disposable earphones connected to the instrument. Each click elicits an identifiable brain wave, which is detected by disposable electrodes placed on the head of the child and analyzed by the screening device. These devices use its AABR signal detection algorithm. The Company’s ABaer, which is a personal computer (PC)-based newborn hearing screening device, offers a combination of AABR, OAE, and diagnostic auditory brainstem response (ABR) technologies in one system. The automatic ABR technology utilizes its point optimized variance ratio (POVR) signal detection algorithm developed by the House Ear Institute. Like its ALGO newborn hearing screeners, this device delivers thousands of soft audible clicks to the newborn’s ears through sound cables and disposable earphones. Each click elicits an identifiable brain wave, which is detected by disposable electrodes placed on the head of the child and analyzed by the screening device.